A detailed history of Klp Kapitalforvaltning As transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 38,900 shares of HRMY stock, worth $1.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
38,900
Previous 25,800 50.78%
Holding current value
$1.32 Million
Previous $711,000 86.08%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 28, 2026

BUY
$25.9 - $34.29 $339,290 - $449,199
13,100 Added 50.78%
38,900 $1.32 Million
Q2 2025

Jul 23, 2025

BUY
$27.94 - $35.91 $78,232 - $100,547
2,800 Added 12.17%
25,800 $815,000
Q4 2024

Feb 11, 2025

BUY
$31.86 - $41.49 $732,780 - $954,270
23,000 New
23,000 $791,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.